First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2011-07-02 03:15:53Open Document File Size: 755,35 KBShare Result on FacebookCityGladesville / Sydney / /CompanyCell Therapeutics Inc. / /EventProduct Issues / Product Recall / FDA Phase / /FacilityUniversity of Melbourne / / /IndustryTermcare protocol / detoxification services / /MedicalConditionalcohol withdrawal syndrome / difficult behaviour Seizures Delirium / withdrawal syndrome / respiratory disease Severe liver disease Hallucinations / Opioid withdrawal syndrome / /OrganizationUniversity of Melbourne / Alcohol and Drug Service / Drug Treatment Policy Unit / NSW Drug and Alcohol Specialist Advisory Service / NSW Health Department / Working Party / Steering Committee / Victorian Department of Human Services / /PersonIan Webster / Ian W Webster / / /PositionAO Chair / Professor / /Productphase Opioid / scale / Protracted / Routine observations / Clinical Institute / alcohol / Seizures Concurrent anxiety / Benzodiazepine / 3.3 Patterns of use Incidental withdrawal Rebound Symptom re-emergence Withdrawal syndrome Managing / 56 56 57 Contents 3 Managing / Opioid / syndrome / Key areas / Opiate / Incidental / Opioid drug use Incidental / Managing opioid / Introduction Detoxification / Short opiate withdrawal scale Opioid / E1 / /ProvinceOrStateVictoria / New South Wales / /RegionSouth Wales / /TechnologySupportive care protocol / /SocialTag |